MODERATOR
:
SPEAKER
(S):
Dr. Judith Hannon, MD, FRCPC, Medical Director, Canadian Blood Services
A Unique Approach to Prenatal Blood Group Serology
Dr. Debra Lane, MD, FRCPC, Medical Officer, Canadian Blood Service
Prof.dr. C. Ellen van der Schoot, MD, PhD, Head department Experimental Immunohematology, Sanquin Blood Supply Foundation
Description
This session will review the history of the development of Rh immune globulin in Canada, describe the standardization of prenatal testing in Western Canada, and highlight the use of maternal plasma for fetal genotyping being developed in Europe -- the possible future of prenatal testing.
-
Explain the future of fetal genotyping using maternal plasma to decrease the use of Rh Immune Globulin from a European perspective.
-
Review the history of the development of Rh Immune Globulin for the prevention of hemolytic disease of the fetus and newborn and reflect on the pioneering work of Dr Bowman.
-
Review the standardization of prenatal testing in Western Canada -- a large area with a relatively small population.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.